Early Antenatal Support for Iron Deficiency Anemia
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18-65
SponsorThomas Jefferson University
About this trial
This is a randomized, controlled multi-site trial of iron therapy in pregnancy. The purpose of this research is to see if second trimester initiation of intravenous (IV) iron therapy is better than oral iron therapy for treatment of anemia in pregnancy by improving blood count, quality of life and reducing side effects.
Eligibility criteria
Qualifiers
Singleton gestation
Gestational age <24 weeks
Baseline Hb ≥9.0 and <11.0 with evidence of iron deficiency anemia
Hb<11.0
Disqualifiers
Sickle cell Disease (NOT sickle cell trait)
Evidence of acute anemia requiring transfusion or IV iron therapy
Major congenital or chromosomal anomaly
Previous use of IV iron in this pregnancy
Trial design
Treatments tested in this trial
- Ferumoxytol
- Ferrous Sulfate
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Thomas Jefferson University
Lead sponsor
Auerbach Hematology and Oncology
Collaborator
Source ClinicalTrials.gov